282 related articles for article (PubMed ID: 25852285)
1. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma--survival and clinical characteristics in relation to various histologic molecular markers in Western patients.
Schöniger-Hekele M; Hänel S; Wrba F; Müller C
Liver Int; 2005 Feb; 25(1):62-9. PubMed ID: 15698400
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients.
Ding Y; Chen B; Wang S; Zhao L; Chen J; Ding Y; Chen L; Luo R
Int J Cancer; 2009 Feb; 124(3):653-8. PubMed ID: 18972435
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
Hu TH; Huang CC; Lin PR; Chang HW; Ger LP; Lin YW; Changchien CS; Lee CM; Tai MH
Cancer; 2003 Apr; 97(8):1929-40. PubMed ID: 12673720
[TBL] [Abstract][Full Text] [Related]
5. [High expression of nucleophosmin/B23 in hepatocellular carcinoma].
Tian QH; Yun JP; Miao J; Chen G; Fu J; Zhang CQ; Su SG; Zhang MF; Wu QL
Zhonghua Bing Li Xue Za Zhi; 2006 Jul; 35(7):407-11. PubMed ID: 17069676
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma.
Chao X; Zhang W; Wu J; Feng X; Shi H; Zhao L; Shen H; Jiang C
Biomed Res Int; 2021; 2021():1971048. PubMed ID: 34485511
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of retinol binding protein 5 is associated with aggressive tumor features in hepatocellular carcinoma.
Ho JC; Cheung ST; Poon WS; Lee YT; Ng IO; Fan ST
J Cancer Res Clin Oncol; 2007 Dec; 133(12):929-36. PubMed ID: 17497168
[TBL] [Abstract][Full Text] [Related]
8. Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma.
Song W; Li H; Tao K; Li R; Song Z; Zhao Q; Zhang F; Dou K
Int J Clin Pract; 2008 Aug; 62(8):1212-8. PubMed ID: 18479363
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma.
Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
J Cancer Res Clin Oncol; 2006 Sep; 132(9):547-55. PubMed ID: 16763805
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and predicted significance of Ubqln2 in patients with hepatocellular carcinoma.
Luo YD; Yu HQ; Liu XY; Huang D; Dai HS; Fang L; Zhang YJ; Lai JJ; Jiang Y; Shuai L; Zhang LD; Chen G; Bie P; Xie CM
Cancer Med; 2020 Jun; 9(12):4083-4094. PubMed ID: 32293796
[TBL] [Abstract][Full Text] [Related]
11. Tumor HLA-DR expression linked to early intrahepatic recurrence of hepatocellular carcinoma.
Matoba K; Iizuka N; Gondo T; Ishihara T; Yamada-Okabe H; Tamesa T; Takemoto N; Hashimoto K; Sakamoto K; Miyamoto T; Uchimura S; Hamamoto Y; Oka M
Int J Cancer; 2005 Jun; 115(2):231-40. PubMed ID: 15688398
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of cytochrome P450 2E1 is associated with poor prognosis of hepatocellular carcinoma.
Ho JC; Cheung ST; Leung KL; Ng IO; Fan ST
Int J Cancer; 2004 Sep; 111(4):494-500. PubMed ID: 15239125
[TBL] [Abstract][Full Text] [Related]
13. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.
Midorikawa Y; Ishikawa S; Iwanari H; Imamura T; Sakamoto H; Miyazono K; Kodama T; Makuuchi M; Aburatani H
Int J Cancer; 2003 Feb; 103(4):455-65. PubMed ID: 12478660
[TBL] [Abstract][Full Text] [Related]
14. Tensin2 variant 3 is associated with aggressive tumor behavior in human hepatocellular carcinoma.
Yam JW; Ko FC; Chan CY; Yau TO; Tung EK; Leung TH; Jin DY; Ng IO
Hepatology; 2006 Oct; 44(4):881-90. PubMed ID: 17006924
[TBL] [Abstract][Full Text] [Related]
15. m
Wu Y; Li L; Wang L; Zhang S; Zeng Z; Lu J; Wang Z; Zhang Y; Zhang S; Li H; Chen T
BMC Cancer; 2024 Apr; 24(1):506. PubMed ID: 38649860
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of down-regulated HINT2 in hepatocellular carcinoma.
Zhou DK; Qian XH; Cheng J; Chen LH; Wang WL
Medicine (Baltimore); 2019 Nov; 98(48):e17815. PubMed ID: 31770197
[TBL] [Abstract][Full Text] [Related]
17. [PTEN expression and its significance in human primary hepatocellular carcinoma].
Wan XW; Wang HY; Jiang M; He YQ; Liu SQ; Cao HF; Qiu XH; Tang L; Wu MC
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):490-2. PubMed ID: 12939185
[TBL] [Abstract][Full Text] [Related]
18. P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection.
Qin LX; Tang ZY; Ma ZC; Wu ZQ; Zhou XD; Ye QH; Ji Y; Huang LW; Jia HL; Sun HC; Wang L
World J Gastroenterol; 2002 Jun; 8(3):459-63. PubMed ID: 12046070
[TBL] [Abstract][Full Text] [Related]
19. [Expressions of phosphorylated-Smad2 and PTEN in hepatocellular carcinomas and adjacent liver tissues].
Wu SK; Wang BJ; Yang Y; Tian YJ; Bao JJ; Feng XH; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2007 Aug; 15(8):567-71. PubMed ID: 17711623
[TBL] [Abstract][Full Text] [Related]
20. [Gene expressions of DNA methyltransferase 1 and human leukocyte antigen-DRalpha in hepatocelluar carcinoma and their clinical significance].
Lv WP; Dong JH; Shi S; Huang ZQ; Guo DY
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):543-7. PubMed ID: 18931722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
